A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction
Table 1
Patient demographics.
Age
BMI before
BMI after
Types of tumor
Type of reconstruction
Time from mastectomy to fat graft
Graft follow-up
Time between MRIs
RTX
Stem group
1
55
24,2
24,0
LCI
LD + IMPL
3 y 8 m
4 y 1 m
12 m
Yes
2
47
25,4
25,8
Mucinous
LD + IMPL
3 y 9 m
3 y 9 m
11 m
Yes
3
49
28,0
27,6
DCI
EXP + IMPL
3 y 2 m
3 y 2 m
15 m
No
4
48
27,2
27,6
DCI
LD + IMPL
3 y 7 m
3 y 2 m
15 m
Yes
5
51
28,7
28,7
DCI
EXP + IMPL
2 y 6 m
3 y 1 m
13 m
No
6
41
27,5
29,1
DCIS
TRAM
4 y 10 m
3 y 1 m
16 m
Yes
7
54
24,0
25,1
DCI
LD + IMPL
3 y
2 y 10 m
13 m
Yes
8
44
23,5
23,3
DCI
LD + IMPL
4 y 1 m
2 y 9 m
16 m
Yes
9
56
23,9
23,9
DCI
TRAM
4 y
2 y 9 m
19 m
Yes
10
58
25,6
25,6
Nontumor
No reconstruction
20 y
2 y 6 m
13 m
No
11
43
30,9
29,7
LCI
Seq explantation
4 y 1 m
1 y 8 m
17 m
Yes
Average
5 y 2 m
36 m
14,5 m
72,7%
Control group
1
51
29,2
29,2
DCI
EXP + IMPL
3 y 2 m
2 y 6 m
16 m
No
2
40
20,8
20,4
Medullar
EXP + IMPL
3 y 1 m
1 y 11 m
19 m
No
3
56
32,4
32,6
DCI
Seq explantation
7 y 3 m
1 y 9 m
19 m
Yes
4
69
25,9
28,1
DCIS
LD + IMPL
16 y 6 m
1 y 3 m
13 m
Yes
5
38
24,1
26,1
DCI
LD + IMPL
2 y 5 m
1 y 1 m
11 m
Yes
6
36
24,1
23,2
DCI
LD + IMPL
8 y 3 m
1 y
11 m
Yes
7
59
25,6
25,2
LCI
EXP + IMPL
5 y 8 m
8 m
7 m
No
8
49
24,9
24,3
DCIS
Seq explantation
2 y 8 m
8 m
7 m
Yes
Average
6 y 1 m
16 m
12,9 m
62,5%
values
0.977
0.765
0.861
nm
nm
nm
nm
0.414
>0.999
BMI, body mass index; LD, latissimus dorsi; Impl, implant; Seq, sequelae; DCI, ductal carcinoma invasive; DCIS, ductal carcinoma in situ; LCI, lobular carcinoma invasive; Exp, expander; m, months; RTX, radiotherapy; nm, not measured; y, years.
